Factors that Influence Healthcare Provider Recommendation of HPV Vaccination

被引:6
|
作者
Btoush, Rula [1 ]
Kohler, Racquel Kelly [2 ,3 ]
Carmody, Dennis P. [1 ]
Hudson, Shawna, V [2 ,4 ]
Tsui, Jennifer [5 ]
机构
[1] Rutgers State Univ, Sch Nursing, 180 Univ Ave, Newark, NJ 07102 USA
[2] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[3] Rutgers Sch Publ Hlth, New Brunswick, NJ USA
[4] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Family Med & Community Hlth, New Brunswick, NJ USA
[5] Univ Southern Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90007 USA
基金
美国国家卫生研究院;
关键词
human papillomavirus vaccine; immunization; healthcare provider; adolescent; attitudes; barriers to vaccination; HUMAN-PAPILLOMAVIRUS VACCINATION; CLINICIAN KNOWLEDGE; ADVISORY-COMMITTEE; STATEWIDE SURVEY; MALE-ADOLESCENTS; INITIATION; BARRIERS; COMMUNICATION; COMPLETION; ATTITUDES;
D O I
10.1177/08901171221091438
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: This study examined factors associated with healthcare providers' (HCPs') recommendation of HPV vaccination for younger and older adolescents. Methods: This is a cross-sectional study, using web-based survey of HCPs in New Jersey in 2018. The study outcome was a dichotomous measure of HCPs' recommendation of the HPV vaccine. The study predictors included practice characteristics (i.e., proportions of race/ethnicity, age groups, insurance type, and VFC recipients) and HCP's characteristics (i.e., specialty and perceived knowledge, effectiveness, concerns, parent- and system-related barriers, and facilitators). Data analysis included logistic regression models using separate blocks for practice and provider characteristics, followed by a backward stepwise approach to determine the surviving predictors. Results: Respondents (N=390) included physicians (75%) and nurse practitioners (25%), specialized in pediatrics (62%), family medicine (20%), and women's health (18%). The HCPs' recommendation rates for HPV vaccination were 56% for younger adolescents (11-13 years old) and 73% for older adolescents (14-17 years old). For younger adolescents, the recommendation rates were significantly higher in practices with higher proportions of younger adolescent, Black and Hispanic patients; among pediatric providers; and with HCPs' higher levels of knowledge and lower levels of concern about the vaccine. For older adolescents, the rates were significantly higher in practices with higher proportions patients who are Hispanic, privately insured, and VFC recipients; among pediatric providers; and with HCPs' higher levels of knowledge and lower levels of concern about the vaccine as well as higher levels of facilitators for recommending the HPV vaccine. Conclusions: Interventions targeting HCPs need to focus on improving their knowledge regarding the vaccine, reduce their concerns around its safety, and utilize facilitators strategies, particularly among non-pediatric providers.
引用
收藏
页码:1152 / 1161
页数:10
相关论文
共 50 条
  • [1] Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination
    Osaghae, Ikponmwosa
    Darkoh, Charles
    Chido-Amajuoyi, Onyema Greg
    Chan, Wenyaw
    Wermuth, Paige Padgett
    Pande, Mala
    Cunningham, Sonia A.
    Shete, Sanjay
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [2] Provider communication and HPV vaccination: The impact of recommendation quality
    Gilkey, Melissa B.
    Calo, William A.
    Moss, Jennifer L.
    Shah, Parth D.
    Marciniak, Macaw W.
    Brewer, Noel T.
    [J]. VACCINE, 2016, 34 (09) : 1187 - 1192
  • [5] Healthcare Provider's Perceived Self-Efficacy in HPV Vaccination Hesitancy Counseling and HPV Vaccination Acceptance
    Osaghae, Ikponmwosa
    Darkoh, Charles
    Chido-Amajuoyi, Onyema Greg
    Chan, Wenyaw
    Padgett Wermuth, Paige
    Pande, Mala
    Cunningham, Sonia A.
    Shete, Sanjay
    [J]. VACCINES, 2023, 11 (02)
  • [6] Provider recommendation for HPV vaccination across Hispanic/Latinx subgroups in the United States
    Reiter, Paul L.
    Pennell, Michael L.
    Martinez, Glenn A.
    Katz, Mira L.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (04) : 1083 - 1088
  • [7] Barriers to the assessment and recommendation of HPV vaccination among healthcare providers in Texas
    Chido-Amajuoyi, Onyema G.
    Osaghae, Ikponmwosa
    Onyeaka, Henry K.
    Shete, Sanjay
    [J]. VACCINE: X, 2024, 18
  • [8] Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020
    Osaghae, Ikponmwosa
    Chandra, Monalisa
    Talluri, Rajesh
    Shete, Sanjay
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [9] Disparities in Healthcare Providers' Recommendation of HPV Vaccination for US Adolescents: A Systematic Review
    Kong, Wei Yi
    Bustamante, Gabriela
    Pallotto, Isabella K.
    Margolis, Marjorie A.
    Carlson, Rebecca
    Mcree, Annie-Laurie
    Gilkey, Melissa B.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 1981 - 1992
  • [10] Patient-level predictors of lack of healthcare provider recommendation for human papillomavirus (HPV) vaccination as reported by childhood cancer survivors and their families.
    York, Jocelyn M.
    Klosky, James L.
    Chen, Yanjun
    Connelly, James A.
    Wasilewski-Masker, Karen
    Giuliano, Anna
    Robison, Leslie L.
    Wong, F. Lennie
    Hudson, Melissa M.
    Bhatia, Smita
    Landier, Wendy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)